TABLE 1 Antibodies Used in Immunophenotypic Analysis
From: Peripheral T-Cell Lymphoma with Aberrant Expression of CD79a and CD20: A Diagnostic Pitfall
Antigen | Name | Source | Result |
|---|---|---|---|
CD45 | LCA | DAKO, Carpinteria, CA | +/− |
CD3 | DAKO | + | |
CD4 | 1F6 | Novocastra Ltd., New Castle Upon Tyne, UK | − |
CD5 | Becton Dickinson, Mountainview, CA | − | |
CD8 | 144 | DAKO | + |
CD20 | L26 | DAKO | + |
CD79a | JCB-117 | DAKO | + |
CD43 | Leu 22 | Beckton-Dickenson | + |
CD45RO | A6 | Immunotech, Westbrooks, ME | − |
CD68 | KP-1 | DAKO | − |
βF-1 | TCR-α/β | T Cell Diagnostics | − |
κ Light Chain | DAKO | − | |
λ Light Chain | DAKO | − | |
TIA-1 | Coulter, Hialeah, FL | + | |
TdT | Supertechs | − | |
MIB-1 | Ki-67 | Immunotech | + |
CD56 | Monosan | + | |
P53 | DAKO | − | |
Bcl-2 | DAKO | + | |
Cyclin D1 | Novocastra | − | |
CD10 | Novacastra | − | |
CD30 | Nocacastra | − | |
Myeloperoxidase | DAKO | − | |
Lysozyme | DAKO | − | |
S-100 | BioGenex | + | |
AE1/AE3 | DAKO | − | |
EMA | DAKO | − |
